Accessibility View Close toolbar

Velscope

GIBSON DENTAL IS PROUD TO INTRODUCE A NEW TOOL FOR ORAL MUCOSAL EXAMINATION

velscope.jpg

Unfortunately Oral Cancer is on the rise around the world. Like other forms of cancer, the earlier it is detected, the easier the treatment and the better the survival rate . Detected at an advanced stage and oral cancer can be very deforming and life expectancy radically reduced. Although we have always performed a visual oral cancer screening periodically on all patients, we at Gibson Dental wanted to make sure that we were providing the most thorough examination. In 2008 we were introduced to the ultimate tool for detecting changes of the oral tissues. With the VELscope®, we can detect the smallest of changes at very early stages. This one tool helps us help give you the best oral exam possible. The VELscope® System is a revolutionary hand-held device that provides us with an easy-to-use adjunctive mucosal examination system for the early detection of abnormal tissue. It is based on the direct visualization of tissue fluorescence and the changes in fluorescence that occur when abnormalities are present. The VELscope® System Hand piece emits a safe blue light into the oral cavity, which excites the tissue from the surface of the epithelium through to the basement membrane and into the stroma beneath, causing it to fluoresce. We are then able to immediately view the different fluorescence responses to help differentiate between normal and abnormal tissue. In fact, the VELscope® System is the only adjunctive device cleared by the FDA and Health Canada to help discover oral mucosal lesions that might not be apparent or visible to the naked eye and to help surgeons determine the appropriate surgical margin for tumor excision. Under examination with the VELscope® System, abnormal tissue typically appears as an irregular, dark area that stands out against the otherwise normal, green fluorescence pattern of surrounding healthy tissue. ORAL CANCER KILLS ONE PERSON EVERY HOUR, 24 HOURS A DAY IN NORTH AMERICA • The incidence of oral cancer increased 11% in the United States in 2007. • Unlike several other cancers, the survival rate for oral cancer has remained unchanged for decades. • The overall 5-year survival rate for oral cancer is 52%, but when discovered early, it increases to 80% – 90%. • Unfortunately, only 35% of oral cancer cases are diagnosed in the early stages. Why? Because there have been few advances made in screening techniques and there are significant limitations inherent to white light and chemiluminescence light examination of the oral mucosa. • Pre-malignant changes actually start below the surface, atthe basement membrane. These changes may not be apparent to the naked eye until the disease progresses to the surface.

Unfortunately Oral Cancer is on the rise around the world. Like other forms of cancer, the earlier it is detected, the easier the treatment and the better the survival rate . Detected at an advanced stage and oral cancer can be very deforming and life expectancy radically reduced. Although we have always performed a visual oral cancer screening periodically on all patients, we at Gibson Dental wanted to make sure that we were providing the most thorough examination. In 2008 we were introduced to the ultimate tool for detecting changes of the oral tissues. With the VELscope®, we can detect the smallest of changes at very early stages. This one tool helps us help give you the best oral exam possible.

The VELscope® System is a revolutionary hand-held device that provides us with an easy-to-use adjunctive mucosal examination system for the early detection of abnormal tissue. It is based on the direct visualization of tissue fluorescence and the changes in fluorescence that occur when abnormalities are present.

The VELscope® System Hand piece emits a safe blue light into the oral cavity, which excites the tissue from the surface of the epithelium through to the basement membrane and into the stroma beneath, causing it to fluoresce. We are then able to immediately view the different fluorescence responses to help differentiate between normal and abnormal tissue. In fact, the VELscope® System is the only adjunctive device cleared by the FDA and Health Canada to help discover oral mucosal lesions that might not be apparent or visible to the naked eye and to help surgeons determine the appropriate surgical margin for tumor excision.

Under examination with the VELscope® System, abnormal tissue typically appears as an irregular, dark area that stands out against the otherwise normal, green fluorescence pattern of surrounding healthy tissue.

ORAL CANCER KILLS ONE PERSON EVERY HOUR, 24 HOURS A DAY IN NORTH AMERICA

  • The incidence of oral cancer increased 11% in the United States in 2007.
  • Unlike several other cancers, the survival rate for oral cancer has remained unchanged for decades.
  • The overall 5-year survival rate for oral cancer is 52%, but when discovered early, it increases to 80% – 90%.
  • Unfortunately, only 35% of oral cancer cases are diagnosed in the early stages. Why? Because there have been few advances made in screening techniques and there are significant limitations inherent to white light and chemiluminescence light examination of the oral mucosa.
  • Pre-malignant changes actually start below the surface, at
  • the basement membrane. These changes may not be apparent to the naked eye until the disease progresses to the surface.

    Contact Us Today!

    We are looking forward to hearing from you!

    OUR LOCATION

    Find us on the map

    HOURS OF OPERATION

    Find Out When We Are Open

    Headerquater

    Monday:

    9:00 am-5:00 pm

    Tuesday:

    8:00 am-3:00 pm

    Wednesday:

    8:00 am-3:00 pm

    Thursday:

    8:00 am-3:00 pm

    Friday:

    8:00 am-12:00 pm

    Saturday:

    Closed

    Sunday:

    Closed